Detection of low-level K65R variants in nucleoside reverse transcriptase inhibitor-naive chronic and acute HIV-1 subtype C infections

J Infect Dis. 2011 Mar 15;203(6):798-802. doi: 10.1093/infdis/jiq126. Epub 2011 Jan 21.

Abstract

To substantiate reports of greater emergence of the K65R nucleoside reverse transcriptase inhibitor (NRTI) mutation in human immunodeficiency virus type 1 (HIV-1) subtype C, we examined natural low-level K65R expression in subtype C relative to subtypes B and AE. We used allele-specific polymerase chain reaction to screen HIV-1 amplified by reverse-transcription high-fidelity polymerase chain reaction from subtype C-infected South African women and infants and CRF01(subtype AE) from Thailand; all subjects were NRTI naive. We found low-level K65R of unknown clinical significance in NRTI-naive subtype C-infected women and infants at frequencies above the natural occurrence in subtypes B and AE. The frequent appearance of subtype C frameshift deletions at codon 65 supports a propensity for transcription error in this region.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anti-HIV Agents / administration & dosage
  • DNA Primers
  • Disease Transmission, Infectious / prevention & control
  • Female
  • HIV Infections / drug therapy
  • HIV Infections / genetics
  • HIV Infections / virology*
  • HIV-1 / classification
  • HIV-1 / drug effects*
  • HIV-1 / genetics*
  • Humans
  • Infant
  • Infant, Newborn
  • Mutation
  • Nevirapine / administration & dosage
  • Pregnancy
  • RNA-Directed DNA Polymerase / genetics*
  • Randomized Controlled Trials as Topic
  • Reverse Transcriptase Inhibitors / pharmacology*
  • Reverse Transcriptase Polymerase Chain Reaction
  • South Africa
  • Thailand

Substances

  • Anti-HIV Agents
  • DNA Primers
  • Reverse Transcriptase Inhibitors
  • Nevirapine
  • RNA-Directed DNA Polymerase